Directory
>
Bob Cass
Bob Cass
Executive Director, ADME & Analytical Chem | Nurix Therapeutics
South San Francisco, California, United States
Bob Cass
Summary
Bob Cass is an accomplished Executive Director with over 30 years of experience in the fields of bioanalysis and drug development, particularly in ADME (Absorption, Distribution, Metabolism, and Excretion). He has a strong track record of problem-solving and strategic planning, with a focus on both nonclinical and clinical drug discovery and development. Bob has held key leadership roles at notable companies, including Nurix Therapeutics and Ultragenyx Pharmaceutical, where he was instrumental in regulatory interactions and project team representation. His expertise spans various areas such as analytical chemistry, pharmacokinetics, and drug metabolism. Bob is also skilled in personnel management and has successfully led teams to optimize workflows and budgets. He is passionate about advancing biopharmaceuticals and has contributed to significant research publications. Additionally, Bob's educational background in chemistry from UC San Diego enhances his technical acumen, making him a valuable asset in the pharmaceutical industry.
Bob Cass
Work Experience
Executive Director, ADME & Analytical Chem at
Nurix Therapeutics
June 2023 - Present
Director, Head of Analytical Chemistry/ADME at
Nurix Therapeutics
April 2020 - December 2023
Director, Bioanalytical/ADME Research at
Ultragenyx
November 2015 - March 2020
Scientific Manager at
Genentech Foundation
August 2013 - October 2015
Associate Director, BA/DMPK at
ACHAOGEN UK LTD
March 2006 - July 2012
Research Scientist at
Triple Royalty Sub LLC
October 1998 - February 2006
Senior Research Associate at
Axys Pharmaceuticals
May 1991 - October 1998
SRA at
Applera Corp
January 1991 - January 1996
SRA at
ARRIS
January 1991 - January 1994
Research Associate at
La Jolla Cancer Research Foundation
October 1987 - October 1990
Bob Cass
Education
University of California San Diego, Chemistry
Frequently Asked Questions about Bob Cass
What is Bob Cass email address?
Bob Cass's primary email address is *****@nurixtx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Bob Cass work for?
Bob Cass is a Executive Director, ADME & Analytical Chem at Nurix Therapeutics, a company specializing in Commercial physical research.
Where Bob Cass graduated from?
Bob Cass holds a degree in Biochemistry from University of California San Diego.
How can I directly contact Bob Cass?
To contact Bob Cass directly, you can use the email address *****@nurixtx.com. Complete contact information is available upon registration with Muraena.
Who is Bob Cass?
Bob Cass is an accomplished Executive Director with over 30 years of experience in the fields of bioanalysis and drug development, particularly in ADME (Absorption, Distribution, Metabolism, and Excretion). He has a strong track record of problem-solving and strategic planning, with a focus on both nonclinical and clinical drug discovery and development. Bob has held key leadership roles at notable companies, including Nurix Therapeutics and Ultragenyx Pharmaceutical, where he was instrumental in regulatory interactions and project team representation. His expertise spans various areas such as analytical chemistry, pharmacokinetics, and drug metabolism. Bob is also skilled in personnel management and has successfully led teams to optimize workflows and budgets. He is passionate about advancing biopharmaceuticals and has contributed to significant research publications. Additionally, Bob's educational background in chemistry from UC San Diego enhances his technical acumen, making him a valuable asset in the pharmaceutical industry.
Bob`s contact details
*****@nurixtx.com
Colleagues
Chief Medical Officer
Sr Vice President
Executive Director, Preclinical Pharmacology
Vice President and Head of Clinical Operations
Vice President, Head of Biometrics
Chief People Officer
Board Member, Chair of Audit Committee and Chair of Nomination and Governance Committee
Vice President and Head of Clinical Science
VP, Alliance & Research Project Management